ADL 10-0116: Began Phase I testing

Adolor Corp. (ADLR), Exton, Penn. Product: ADL 10-0116 Business: Neurological Therapeutic category: Receptor agonist Target: Opioid receptors Description: Oral peripherally restricted kappa opioid re...